This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Treatments:Cancer
From Proteopedia
(Difference between revisions)
| (10 intermediate revisions not shown.) | |||
| Line 11: | Line 11: | ||
* Zelboraf - Generic: Vemurafenib (Formerly: PLX-4032) | * Zelboraf - Generic: Vemurafenib (Formerly: PLX-4032) | ||
=====Chemotherapy===== | =====Chemotherapy===== | ||
| - | * Platinol - Generic: [[Cisplatin]] | + | * [[Platinol]] - Generic: [[Cisplatin]] |
=====[[Dihydrofolate reductase|Dihydrofolate Reductase]] Inhibitor===== | =====[[Dihydrofolate reductase|Dihydrofolate Reductase]] Inhibitor===== | ||
* Alimta - Generic: Pemetrexed | * Alimta - Generic: Pemetrexed | ||
* Folotyn - Generic: Pralatrexate | * Folotyn - Generic: Pralatrexate | ||
| - | * [[Methotrexate]] | + | * [[Methotrexate]] - Trade names: [[Trexall]], [[Rheumatrex]], [[Otrexup]] |
* Raltitrexed | * Raltitrexed | ||
| - | =====[[Epidermal Growth Factor Receptor]] | + | =====[[Epidermal Growth Factor Receptor]] Inhibitors===== |
* [[Herceptin]] - Generic: [[Trastuzumab]] | * [[Herceptin]] - Generic: [[Trastuzumab]] | ||
* [[Iressa]] - Generic: [[Gefitinib]] | * [[Iressa]] - Generic: [[Gefitinib]] | ||
| Line 23: | Line 23: | ||
* [[Tykerb]] - Generic: [[Lapatinib]] | * [[Tykerb]] - Generic: [[Lapatinib]] | ||
=====Estrogen Receptor Modulator===== | =====Estrogen Receptor Modulator===== | ||
| - | * Evista - Generic: Raloxifene | + | * [[Evista]] - Generic: [[Raloxifene]] |
* Fareston - Generic: Toremifene | * Fareston - Generic: Toremifene | ||
* [[Nolvadex]] - Generic: [[Tamoxifen]] | * [[Nolvadex]] - Generic: [[Tamoxifen]] | ||
| - | =====Multiple Receptor [[Tyrosine kinase]] ([[VEGFR]], PDGFR, [[EGFR]], KIT, Abl) | + | =====mTOR inhibitor===== |
| + | * Rapamune - Generic: Sirolimus ([[Rapamycin]]) | ||
| + | * Afinitor - Generic: Everolimus | ||
| + | * Torisel - Generic: Temsirolimus | ||
| + | =====Multiple Receptor [[Tyrosine kinase]] ([[VEGFR]], PDGFR, [[EGFR]], KIT, Abl) Inhibitors===== | ||
* [[Gleevec]] - Generic: [[Imatinib]] | * [[Gleevec]] - Generic: [[Imatinib]] | ||
* [[Nexavar]] - Generic: [[Sorafenib]] | * [[Nexavar]] - Generic: [[Sorafenib]] | ||
| Line 32: | Line 36: | ||
* [[Sutent]] - Generic: [[Sunitinib]] | * [[Sutent]] - Generic: [[Sunitinib]] | ||
* [[Tasigna]] - Generic: [[Nilotinib]] | * [[Tasigna]] - Generic: [[Nilotinib]] | ||
| + | * [[Ibrutinib]] - brand name: [[Imbruvica]] | ||
=====[[Vascular Endothelial Growth Factor]] Inhibitor===== | =====[[Vascular Endothelial Growth Factor]] Inhibitor===== | ||
* [[Avastin]] - Generic: [[Bevacizumab]] | * [[Avastin]] - Generic: [[Bevacizumab]] | ||
| + | =====Poly ADP ribose polymerase (PARP) inhibitors===== | ||
| + | * [[Olaparib]] - brand name [[Lynparza]] | ||
| + | =====[[Cyclin-dependent kinases]] inhibitors===== | ||
| + | * [[Palbociclib]] - brand name [[Ibrance]] | ||
| + | * [[Abemaciclib]] - brand name [[Verzenio]] | ||
| + | * [[Ribociclib]] - brand name [[Kisqali]] | ||
</td> | </td> | ||
</tr> | </tr> | ||
</table> | </table> | ||
__NOTOC__ | __NOTOC__ | ||
Current revision
Anti-CD20 Monoclonal Antibody
Anti-melanoma Monoclonal Antibody
B-Raf Kinase Inhibitor
ChemotherapyDihydrofolate Reductase Inhibitor
Epidermal Growth Factor Receptor Inhibitors
Estrogen Receptor Modulator
mTOR inhibitor
Multiple Receptor Tyrosine kinase (VEGFR, PDGFR, EGFR, KIT, Abl) Inhibitors
Vascular Endothelial Growth Factor Inhibitor
Poly ADP ribose polymerase (PARP) inhibitorsCyclin-dependent kinases inhibitors
|
Proteopedia Page Contributors and Editors (what is this?)
David Canner, Alexander Berchansky, Michal Harel, Karsten Theis
